BioCryst Pharmaceuticals Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Millions MXN. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Apr '25 Apr 28, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	36,751	32,457	20,740	41,746	51,090	26,175	Upgrade
Market Cap Growth	56.49%	56.49%	-50.32%	-18.29%	95.19%	161.10%	Upgrade
Enterprise Value	46,991	43,128	28,311	47,499	53,366	24,930	Upgrade
Last Close Price	138.00	155.00	113.92	215.00	255.00	148.00	Upgrade
PS Ratio	3.91	3.46	3.70	7.90	15.86	73.85	Upgrade
PB Ratio	-3.71	-3.27	-2.69	-7.26	-23.29	-68.29	Upgrade
EV/Sales Ratio	5.30	4.59	5.05	8.99	16.56	70.34	Upgrade
EV/EBITDA Ratio	-	1194.32	-	-	-	-	Upgrade
Debt / Equity Ratio	-1.77	-1.77	-1.86	-2.52	-5.54	-14.51	Upgrade
Debt / EBITDA Ratio	208.58	208.58	-	-	-	-	Upgrade
Asset Turnover	0.90	0.90	0.62	0.48	0.34	0.07	Upgrade
Inventory Turnover	10.11	10.11	7.71	12.00	18.93	-	Upgrade
Quick Ratio	2.49	2.49	2.97	4.50	5.18	2.93	Upgrade
Current Ratio	2.63	2.63	3.31	4.89	5.46	3.07	Upgrade
Return on Equity (ROE)	-	-	-	-	-	-1925.37%	Upgrade
Return on Assets (ROA)	-0.16%	-0.16%	-11.57%	-16.30%	-24.07%	-41.60%	Upgrade
Return on Capital (ROIC)	-0.21%	-0.21%	-14.70%	-19.88%	-29.76%	-55.37%	Upgrade
Earnings Yield	-5.04%	-5.71%	-18.47%	-11.55%	-7.39%	-13.90%	Upgrade
FCF Yield	-3.01%	-3.41%	-7.93%	-7.63%	-5.80%	-10.31%	Upgrade
Buyback Yield / Dilution	-7.54%	-7.54%	-3.38%	-3.79%	-7.08%	-44.70%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.